HOME ·

R&D Progress

ASCENTAGE (06855.HK): Four Assets Chosen for ASH 2026, APG-5918 Oral
Tags：
ASCENTAGE06855.HKR&D Progress
2026-11-05
GENSCRIPT BIO (01548.HK): Legend to Present CARVYKTI Data at ASH 2026
Tags：
GENSCRIPT BIO01548.HKR&D Progress
2026-11-05
CSPC PHARMA (01093.HK): SYS6057 RSV vaccine Phase I begins
Tags：
CSPC PHARMA01093.HKR&D Progress
2026-11-02
CSPC PHARMA (01093.HK): SYS6052 shingles vaccine trial starts
Tags：
CSPC PHARMA01093.HKR&D Progress
2026-11-02
3D MEDICINES (01244.HK): 3D189/GPS Phase 3 REGAL Hits Pre-specified 80 Events
Tags：
3D MEDICINES01244.HKR&D Progress
2026-10-29
JUNSHI BIO (01877.HK): JS207 + JS007 Phase III HCC Doses First Patient
Tags：
JUNSHI BIO01877.HKR&D Progress
2026-10-29
HENGRUI PHARMA (01276.HK): ADC filing accepted for priority review
Tags：
HENGRUI PHARMA01276.HKR&D Progress
2026-10-29
RECBIO-B (02179.HK): REC610 Phase III trial done, report received
Tags：
RECBIO-B02179.HKR&D Progress
2026-10-29
LIVZON PHARMA (01513.HK): Tiange Dingxuan wins trial approval
Tags：
LIVZON PHARMA01513.HKR&D Progress
2026-10-27
LIVZON PHARMA (01513.HK): Wandai Tang Granules win approval
Tags：
LIVZON PHARMA01513.HKR&D Progress
2026-10-27
HENGRUI PHARMA (01276.HK): Three drugs win clinical trial approval
Tags：
HENGRUI PHARMA01276.HKR&D Progress
2026-10-26
LONGBIO-B (01779.HK): LP-005 hits Phase II endpoints in PNH
Tags：
LongBio-B01779.HKR&D Progress
2026-10-21
SBP GROUP (01177.HK): TQC2731 Phase III fully enrolled in CRSwNP
Tags：
SBP GROUP01177.HKR&D Progress
2026-10-21
ASCENTAGE (06855.HK): Lisaftoclax wins breakthrough status in CLL/SLL
Tags：
ASCENTAGE06855.HKR&D Progress
2026-10-21
SIHUAN PHARM (00460.HK): Two aesthetics products approved in HK
Tags：
SIHUAN PHARM00460.HKR&D Progress
2026-10-20
OCUMENSION-B (01477.HK): OT-101 Phase III meets China endpoint
Tags：
OCUMENSION-B01477.HKR&D Progress
2026-10-20
INSILICO (03696.HK): Servier AI drug discovery milestone hit
Tags：
Insilico03696.HKR&D Progress
2026-10-20
ASCLETIS-B (01672.HK): Weekly oral peptide data positive
Tags：
ASCLETIS-B01672.HKR&D Progress
2026-10-20
SBP GROUP (01177.HK): TQ-A3334, Bepirovirsen Data Picked for AASLD
Tags：
SBP GROUP01177.HKR&D Progress
2026-10-14
HENGRUI PHARMA (01276.HK): SHR-3201 wins trial approval for AD
Tags：
HENGRUI PHARMA01276.HKR&D Progress
2026-10-13
12345..6